Literature DB >> 17680774

Differential regulation of class IA phosphoinositide 3-kinase catalytic subunits p110 alpha and beta by protease-activated receptor 2 and beta-arrestins.

Ping Wang1, Puneet Kumar, Chang Wang, Kathryn A Defea.   

Abstract

PAR-2 (protease-activated receptor 2) is a GPCR (G-protein-coupled receptor) that can elicit both G-protein-dependent and -independent signals. We have shown previously that PAR-2 simultaneously promotes Galphaq/Ca2+-dependent activation and beta-arrestin-1-dependent inhibition of class IA PI3K (phosphoinositide 3-kinase), and we sought to characterize further the role of beta-arrestins in the regulation of PI3K activity. Whereas the ability of beta-arrestin-1 to inhibit p110alpha (PI3K catalytic subunit alpha) has been demonstrated, the role of beta-arrestin-2 in PI3K regulation and possible differences in the regulation of the two catalytic subunits (p110alpha and p110beta) associated with p85alpha (PI3K regulatory subunit) have not been examined. In the present study we have demonstrated that: (i) PAR-2 increases p110alpha- and p110beta-associated lipid kinase activities, and both p110alpha and p110beta are inhibited by over-expression of either beta-arrestin-1 or -2; (ii) both beta-arrestin-1 and -2 directly inhibit the p110alpha catalytic subunit in vitro, whereas only beta-arrestin-2 directly inhibited p110beta; (iii) examination of upstream pathways revealed that PAR-2-induced PI3K activity required the small GTPase Cdc (cell-division cycle)42, but not tyrosine phosphorylation of p85; and (iv) beta-arrestins inhibit PAR-2-induced Cdc42 activation. Taken together, these results indicated that beta-arrestins could inhibit PAR-2-stimulated PI3K activity, both directly and through interference with upstream pathways, and that the two beta-arrestins differ in their ability to inhibit the p110alpha and p110beta catalytic subunits. These results are particularly important in light of the growing interest in PAR-2 as a pharmacological target, as commonly used biochemical assays that monitor G-protein coupling would not screen for beta-arrestin-dependent signalling events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17680774      PMCID: PMC2267348          DOI: 10.1042/BJ20070483

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Over-expression of the p110beta but not p110alpha isoform of PI 3-kinase inhibits motility in breast cancer cells.

Authors:  Shu-Chin Yip; Mirvat El-Sibai; Karen M Hill; Haiyan Wu; Zheng Fu; John S Condeelis; Jonathan M Backer
Journal:  Cell Motil Cytoskeleton       Date:  2004-11

2.  Feedback regulation of beta-arrestin1 function by extracellular signal-regulated kinases.

Authors:  F T Lin; W E Miller; L M Luttrell; R J Lefkowitz
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

3.  Trafficking of proteinase-activated receptor-2 and beta-arrestin-1 tagged with green fluorescent protein. beta-Arrestin-dependent endocytosis of a proteinase receptor.

Authors:  O Déry; M S Thoma; H Wong; E F Grady; N W Bunnett
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

4.  Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85.

Authors:  Y Zheng; S Bagrodia; R A Cerione
Journal:  J Biol Chem       Date:  1994-07-22       Impact factor: 5.157

5.  beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor.

Authors:  F T Lin; Y Daaka; R J Lefkowitz
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

6.  Rac GTPase interacts specifically with phosphatidylinositol 3-kinase.

Authors:  G M Bokoch; C J Vlahos; Y Wang; U G Knaus; A E Traynor-Kaplan
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

7.  Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers.

Authors:  Y R Hadari; E Tzahar; O Nadiv; P Rothenberg; C T Roberts; D LeRoith; Y Yarden; Y Zick
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

8.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

Authors:  L M Luttrell; S S Ferguson; Y Daaka; W E Miller; S Maudsley; G J Della Rocca; F Lin; H Kawakatsu; K Owada; D K Luttrell; M G Caron; R J Lefkowitz
Journal:  Science       Date:  1999-01-29       Impact factor: 47.728

9.  Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85.

Authors:  K Yamamoto; D Altschuler; E Wood; K Horlick; S Jacobs; E G Lapetina
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

Review 10.  Phosphoinositide kinases.

Authors:  D A Fruman; R E Meyers; L C Cantley
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

View more
  15 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

2.  Tyrosine phosphorylation of the Gα-interacting protein GIV promotes activation of phosphoinositide 3-kinase during cell migration.

Authors:  Changsheng Lin; Jason Ear; Yelena Pavlova; Yash Mittal; Irina Kufareva; Majid Ghassemian; Ruben Abagyan; Mikel Garcia-Marcos; Pradipta Ghosh
Journal:  Sci Signal       Date:  2011-09-27       Impact factor: 8.192

Review 3.  Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction.

Authors:  K Defea
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 4.  Endosomes: a legitimate platform for the signaling train.

Authors:  Jane E Murphy; Benjamin E Padilla; Burcu Hasdemir; Graeme S Cottrell; Nigel W Bunnett
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

5.  Distinct functional outputs of PTEN signalling are controlled by dynamic association with β-arrestins.

Authors:  Evelyne Lima-Fernandes; Hervé Enslen; Emeline Camand; Larissa Kotelevets; Cédric Boularan; Lamia Achour; Alexandre Benmerah; Lucien C D Gibson; George S Baillie; Julie A Pitcher; Eric Chastre; Sandrine Etienne-Manneville; Stefano Marullo; Mark G H Scott
Journal:  EMBO J       Date:  2011-06-03       Impact factor: 11.598

Review 6.  The Diverse Roles of Arrestin Scaffolds in G Protein-Coupled Receptor Signaling.

Authors:  Yuri K Peterson; Louis M Luttrell
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

7.  Non-visual arrestins regulate the focal adhesion formation via small GTPases RhoA and Rac1 independently of GPCRs.

Authors:  Whitney M Cleghorn; Nada Bulus; Seunghyi Kook; Vsevolod V Gurevich; Roy Zent; Eugenia V Gurevich
Journal:  Cell Signal       Date:  2017-11-11       Impact factor: 4.315

8.  Proteinase-activated receptor 2 (PAR2) decreases apoptosis in colonic epithelial cells.

Authors:  Vadim Iablokov; Christina L Hirota; Michael A Peplowski; Rithwik Ramachandran; Koichiro Mihara; Morley D Hollenberg; Wallace K MacNaughton
Journal:  J Biol Chem       Date:  2014-10-20       Impact factor: 5.157

9.  Genetical genomic determinants of alcohol consumption in rats and humans.

Authors:  Boris Tabakoff; Laura Saba; Morton Printz; Pam Flodman; Colin Hodgkinson; David Goldman; George Koob; Heather N Richardson; Katerina Kechris; Richard L Bell; Norbert Hübner; Matthias Heinig; Michal Pravenec; Jonathan Mangion; Lucie Legault; Maurice Dongier; Katherine M Conigrave; John B Whitfield; John Saunders; Bridget Grant; Paula L Hoffman
Journal:  BMC Biol       Date:  2009-10-27       Impact factor: 7.431

10.  Beta-arrestin inhibits CAMKKbeta-dependent AMPK activation downstream of protease-activated-receptor-2.

Authors:  Ping Wang; Yong Jiang; Yinsheng Wang; John Y Shyy; Kathryn A DeFea
Journal:  BMC Biochem       Date:  2010-09-21       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.